Navigation Links
U.S. Court of Appeals Affirms Validity of Lilly's Strattera Patent
Date:7/29/2011

INDIANAPOLIS, July 29, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Court of Appeals for the Federal Circuit has overturned a prior ruling by the U.S. District Court for the District of New Jersey and has upheld the validity of the company's method-of-use patent on Strattera® (atomoxetine). In the case of Eli Lilly and Company v. Actavis Elizabeth LLC, et al, the court ruled in favor of Lilly, upholding the method-of-use patent which provides protection for Strattera through May of 2017.

"We are pleased with today's ruling from the Court of Appeals regarding Strattera's method-of-use patent and remain confident that the patent is valid and enforceable," said Robert A. Armitage, senior vice president and general counsel for Lilly. "In overturning the prior district court ruling, we believe that the Court fairly applied long-standing patent law principles."

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.  Additional information about Lilly is available at www.lilly.com.  C-LLY

This release contains forward-looking statements regarding the U.S. Strattera patent litigation. These statements are based on management's current expectations but actual results may differ materially.  There can be no assurance that the company will prevail in any appeal. Other risk factors that may affect the company's results can be found in the company's latest Forms 10-K and 10-Q filed with the U.S. Securities and Exchange Commission.


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
2. Heygood, Orr & Pearson: Court of Appeals Affirms $16.56 Million Judgment in Defective Fentanyl Patch Case
3. Actavis Hails U.S. Supreme Court Decision in Labeling Cases
4. Watson Confirms Court Decision Rejecting Tevas Motion to Prevent Launch of Generic SEASONIQUE®
5. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
6. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
7. Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
8. Court Certifies Overtime Class Action Against Forest Labs, According to The Ottinger Firm, P.C.
9. Lilly Comments on Court Ruling in Amylin Litigation
10. Federal Court Asked to Compel Decision in Marijuana Scheduling Action
11. 83 Cases of Autism Associated with Childhood Vaccine Injury Compensated in Federal Vaccine Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... COTTAGE, New York , July 30, 2015 /PRNewswire/ ... release of its latest report titled, "Continuous Glucose Monitoring ... - 2020". According to the report, the global continuous ... Mn in 2014 and is expected to reach US$ ... during the forecast period, 2015 to 2020. ...
(Date:7/30/2015)... , July 30, 2015  Medimetriks Pharmaceuticals, ... the second Phase III clinical study for Ozenoxacin, ... impetigo.  Medimetriks owns the exclusive U.S. rights to ... trial, conducted at 44 centers with an emphasis ... patients aged 2 months and older with a ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
... Oct. 19 The board of directors of Eli Lilly and ... fourth quarter of 2009 of $0.49 a share on outstanding common ... the first three quarters of 2009 and brings the total annual ... http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO ) , The dividend is payable December ...
... The U.S. Food and Drug Administration today approved Votrient ... since 2005. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ... the growth of new blood vessels needed for solid tumors ... people with advanced renal cell carcinoma, a type of kidney ...
Cached Medicine Technology:FDA Approves New Treatment for Advanced Form of Kidney Cancer 2
(Date:7/31/2015)... Atlanta, GA (PRWEB) , ... July 31, 2015 ... ... the five new industry players to know in predictive health analytics , ... machine learning technologies. The firm creates predictive software that targets patient and population ...
(Date:7/31/2015)... ... July 31, 2015 , ... Jacksonville-based drug and alcohol ... North Conference Center. The medical community, social workers, law enforcement, and government officials ... aligned in the effort to better understand and combat sex trafficking. Lead by ...
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... According to the article ... floor of the Pasadena courthouse was contained and extinguished by the city’s fire department before ... in the building at the time of the fire, and it was a fire alarm ...
(Date:7/31/2015)... Texas (PRWEB) , ... July 31, 2015 , ... As ... Sitter believes community involvement and support of animal welfare organizations is essential to the ... the third consecutive year in the National Association of Professional Pet Sitters (NAPPS) annual ...
(Date:7/31/2015)... ... 31, 2015 , ... Girl Scouts of Historic Georgia and Peach State Health ... Scout "Be a Friend First" program. Representatives from Peach State Health Plan presented a ... Health Plan and our parent company, Centene Corporation, are dedicated to raising anti-bullying awareness. ...
Breaking Medicine News(10 mins):Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2
... FRIDAY, Jan. 14 (HealthDay News) -- Exposure to bright artificial ... your sleep and may increase the risk of high blood ... included 116 healthy participants, aged 18 to 30, who were ... eight hours before bedtime for five consecutive days. Blood plasma ...
... 2011) Based on a survey of thousands of ... physician-researchers from Los Angles Biomedical Research Institute at Harbor-UCLA ... a guide to the top 1 percent of physicians ... "America,s Top Doctors," chose another 16 LA BioMed physician-researchers ...
... Ont., Jan. 13, 2011Patients who must return to dialysis ... on home dialysis as hospital dialysis, but few choose ... Perl, a nephrologist at St. Michael,s Hospital. Despite ... an increasing number of patients return to dialysis. These ...
... study by Ohio State University cancer researchers provides a ... of targeted agents, one that inhibits an overactive, cancer-causing ... that silence genes that normally prevent cancer. Both types ... in clinical trials, the researchers note. The findings, published ...
... The more you walk, the lower your risk of diabetes, ... who participated in a study to map diabetes levels across ... at the start of the study and provided details about ... given a pedometer and instructed how to use it. ...
... 2011 AIUM Annual Convention and Preconvention Program, the only ... all disciplines of medical ultrasound, to be held April ... convention program incorporates an unprecedented selection of scientific research ... a focus on emerging applications and patient safety. ...
Cached Medicine News:Health News:Bright Lights at Night May Raise Diabetes Risk 2Health News:LA BioMed researchers among 'America's Top Doctors' 2Health News:Home dialysis effective for kidney patients after transplant fails 2Health News:Study provides molecular rationale for combining targeted agents to treat breast cancer 2Health News:The More You Walk, the Lower Your Diabetes Risk: Study 2Health News:AIUM unveils original features at 2011 convention 2
... stabilizer is an example of advanced technology ... the compression and comfort of a soft ... an ankle stirrup. A plastic exoskeleton ... fabric, forming a network of strategically placed ...
... with three regulated communicative chambers. It's one ... of low profile pneumatics to dramatically increase ... in other stirrups. The "slow rebound" air ... is enclosed and protected to prevent puncture. ...
... X-Brace is a cost effective stirrup designed to ... rehabilitation. It is lower in profile than other ... increasing potential patient compliance. The X-Brace offers the ... instep, and everts the foot. This allows the ...
... has a rigid shell with a vacuum liner ... The VacoSplint is a non-weight bearing splint. Once ... should transfer to the STORM walker boot., ... liner from the STORM and insert the vacuum ...
Medicine Products: